Navigation Links
European Liquid Chromatography Reagents Market is Expected to Reach $1581.8 Million in 2018 - New Report by MicroMarket Monitor
Date:7/25/2014

orts

North American Liquid Chromatography Reagents Market
Liquid chromatography is a technique in which the mobile phase is liquid. The separation occurs due to the interactions of the sample with the mobile and stationary phase. Liquid chromatography is the most widely used chromatographic technique for preparative applications. It is further divided into high pressure liquid chromatography (HPLC), ultra high-pressure liquid chromatography (UHPLC), and low pressure liquid chromatography (LPLC).Liquid chromatography is extensively used in the pharmaceutical industry. It plays a very significant role in various phases of drug discovery, and is used for controlling the quality and consistency of a chemical entity or active substance. The pharmaceutical industry is growing at a very fast pace, especially in emerging economies such as India, which in-turn is driving the market for liquid chromatography and its reagents.

http://www.micromarketmonitor.com/market/north-america-liquid-chromatography-reagents-9666187252.html

Asian Liquid Chromatography Reagents Market
Liquid Chromatography Reagents-Asia can be segmented by Companies, Applications, Products, Processes, Endusers and Macro Indicators. Companies of Liquid Chromatography Reagents-Asia are Agilent Technologies, Phenomenex, Inc., GE Healthcare, W.R. Grace & Co., Helena Laboratories, Thermo Fisher Scientific, Waters Corporation and Other Companies. Applications of Liquid Chromatography Reagents-Asia are Analytic Chromatography Reagents and Preparative Chromatography Reagents. Products of Liquid Chromatography Reagents-Asia are Column Chr
'/>"/>

Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. U.S and European Video, High – Tech and Integrated Operating Room Market Outlook to 2019: Led by STERIS, Stryker and Karl Storz
2. EORTC presents European solution for effective cancer drug development
3. United European Gastroenterology calls for increase in nurse endoscopy training across Europe
4. Richard Sylvester receives European Urology 2014 Platinum Award for Excellence
5. Queens University Vice-Chancellor receives top European award
6. US, European cholesterol guidelines differ in statin use recommendations
7. Better nurse staffing and education reduces patient deaths in European hospitals
8. European Home Healthcare Market (Respiratory Therapy, Rehabilitation Therapy) worth $57.2 Billion by 2017 - New Report by MarketsandMarkets
9. European Anesthesia, Respiratory and Sleep Management Device Market
10. Selexis SA Names Dr. Marco Bocci Director of European Sales and Business Development
11. European Market for Multiparameter Patient Monitoring Solutions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/16/2014)... New York (PRWEB) September 16, 2014 ... Pinnacle hip replacement lawsuit ( http://www.consumerinjurylawyers.com/depuy-pinnacle/lawsuit ) now ... of Texas has moved into its third week, ... this week’s witnesses included a DePuy Orthopaedics vice ... performed on the metal-on-metal Pinnacle hip. * (Herlihy-Paoli ...
(Date:9/16/2014)... School of Medicine have launched a phase 1 human ... a new monoclonal antibody for patients with chronic lymphocytic ... in adults. , The new antibody targets ... development and exploited by cancer cells to promote tumor ... of all cancer-related deaths. , Because ROR1 ...
(Date:9/16/2014)... 16, 2014 RxAnte, the leading ... and targeted clinical programs, today announced key changes ... the Company’s drive to improve medication effectiveness through ... programs. On September 2, 2014, Brock Hardaway, chief ... announced that RxAnte founder and President Josh Benner ...
(Date:9/16/2014)... (PRWEB) September 16, 2014 Former Major ... today after undergoing successful heart transplantation surgery at Allegheny ... Tekulve, who spent most of his 16-year baseball career ... as a commentator for Root Sports Pittsburgh, was discharged ... surgeon, Stephen Bailey, MD, surgical director of AGH’s heart ...
(Date:9/16/2014)... no longer be used to ascertain the eventual scale ... University of Warwick. , Dr Thomas House, of the ... data from past outbreaks that successfully replicated their eventual ... Ebola Outbreaks and published by eLife , shows ... 2014 outbreak to the model that it is, according ...
Breaking Medicine News(10 mins):Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Latest Testimony in Federal Pinnacle Hip Replacement Trial 2Health News:DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Latest Testimony in Federal Pinnacle Hip Replacement Trial 3Health News:Novel drug targeting leukemia cells enters clinical trial 2Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 2Health News:Millennium Health’s RxAnte Subsidiary Announces Leadership Promotions 3Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 2Health News:Former Pittsburgh Pirates Pitcher and Baseball Analyst Kent Tekulve Undergoes Successful Heart Transplant at Allegheny General Hospital 3Health News:Ebola outbreak 'out of all proportion' and severity cannot be predicated 2
... ... of young adults with disabilities and adjusting to college life. , ... Wellesley, MA (PRWEB) Jan. 26, 2010 ... services, announced that its ChildRC.com web site now features a very informative and exciting ...
... , WASHINGTON , Jan. 26 ... Dateline NBC documentary on patients who have insurance but not adequate ... to deal with the lack of legal accountability for insurers and ... , The nonprofit consumer group called upon Obama to close ...
... , WASHINGTON , Jan. 26 The ... nonpartisan individual membership association of state legislators -- congratulates Pennsylvania ... for filing House Bills 2053 and 2179, which protect the ... Baker and Schroder will hold a joint press conference tomorrow at ...
... NC What does evolution a field that often ... with preventing and treating disease in our lifetime? A lot, ... may soon be tested on evolution in medical entrance and ... A collection of articles in the January 26 issue ...
... European Commission consultation on the EU Clinical Trials Directive, ... proposals by its member organisations for adapting the Directive,s ... treatment. Since the implementation of the Directive ... concerned about the detrimental effect it has had, particularly ...
... 2010 A Universit de Montral research team is developing ... brain to stop eating. "Mice deprived of leptin will not ... around," says Mose Bendayan, a pathology professor at the Universit ... protein extensively. Leptin regulates appetite in mammals and its ...
Cached Medicine News:Health News:ChildRC.com Features “Acclimating To College Life In A Wheelchair” 2Health News:Obama: Make Equal Justice for Patients a State of the Union Pledge & Re-establish White House Office of Consumer Affairs 2Health News:Obama: Make Equal Justice for Patients a State of the Union Pledge & Re-establish White House Office of Consumer Affairs 3Health News:Pennsylvania Legislators Stand for Health Care Freedom 2Health News:Pennsylvania Legislators Stand for Health Care Freedom 3Health News:Pennsylvania Legislators Stand for Health Care Freedom 4Health News:Medical students may soon be tested on evolution 2Health News:Medical students may soon be tested on evolution 3Health News:European Cancer Organization supports a revision of the EU Clinical Trials Directive 2Health News:European Cancer Organization supports a revision of the EU Clinical Trials Directive 3Health News:A gimmick-free weight-loss pill in the works 2
(Date:9/16/2014)... 2014 Adaptive Biotechnologies, a clinical stage diagnostics ... the adaptive immune system, is pleased to announce the ... Officer (CCO). The addition of Brain to the Company,s ... leading global healthcare companies, including Dean Schorno ... Genomic Health and Sean Nolan (CTO) from ...
(Date:9/16/2014)... QPID Health , a leader in clinical intelligence software, ... Boston and their first West Coast location in ... Street in Boston , and will house product ... Southern California office will be located at ... the demands of customers nationwide.  Both new locations will be ...
(Date:9/16/2014)... Sept. 16, 2014  Formex, LLC ("Formex"), ... that Mr. Greg Weilersbacher joined Formex as Director ... Greg Weilersbacher has ... focused expertise in Quality Assurance, Facility Validation, ... Weilersbacher brings to Formex a diverse wealth ...
Breaking Medicine Technology:Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 2Veteran Genoptix and Gen-Probe Executive, Brian Hansen, joins Adaptive Biotechnologies as Chief Commercial Officer 3QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego 2Greg Weilersbacher Joins Formex, LLC As Director of Quality Assurance and Quality Control 2
... R.I., Aug. 16, 2011 Medicare Part D beneficiaries ... pay 100 percent of previously subsidized prescription costs, are ... are to switch to more affordable or generic medications, ... concludes. (Logo: http://photos.prnewswire.com/prnh/20090226/NE75914LOGO) The ...
... Savient Pharmaceuticals, Inc. (NASDAQ: SVNT ) ... Phase III clinical studies in patients with refractory chronic ... of the American Medical Association ( JAMA ). ... significant and sustained reductions in uric acid levels along ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 2CVS Caremark, Harvard and Brigham and Women's Researchers Say Medicare 'Donut Hole' Can Lead to a Decrease in Medication Adherence 3Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 2Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 3Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 4Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 5Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 6Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 7Savient Pharmaceuticals Announces Publication of Pivotal Phase III KRYSTEXXA® Data in JAMA Demonstrating Significant Benefits in Refractory Chronic Gout Patients 8
ACMI™ COAG Bipolar Laparoscopy Probes provide 360 of hemostatis, bipolar safety, blunt dissection, irrigation, and suction in one instrument....
An In Vitro Nucleic Acid Hybridization Assay with Signal Amplification using Microplate Chemiluminescence for the Qualitative Detection of Human Papillomavirus (HPV) Types 16, 18, 31, 33, 35, 39, 45,...
... first time in the world, there is a ... to diagnose VVC in female patients. CanDia5® is ... detect the Candida antigens almost instantaneously (within 5 ... blood. There is no similar POC product for ...
... test for Candida albicans in only ... utilizes two enzyme color reactions to ... to read. AlbiQuicktm is performed on ... wells. Incubation time is only five ...
Medicine Products: